Paper pubblicati

Filtri

A real-world study on tezepelumab effectiveness in severe asthma focusing on small airway dysfunction

Francesco Menzella et al.

Asthma & Immunology · 2025

Editorial support

Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation

Alessandra Vultaggio et al.

Expert Opinion on Biological Therapy · 2025

Editorial support

Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma

Francesco Menzella et al.

Journal of Clinical Medicine (MDPI) · 2025

Editorial support

Key decision factors in second-line therapy: Expert insights on HR+/HER2-metastatic breast cancer post-CDK4/6 inhibitor progression

Roberto Buonaiuto et al.

Cancer Treatment Reviews · 2025

Editorial support

In vitro antimicrobial activity of an oral spray combining 0.15% benzydamine hydrochloride and 0.5% cetylpyridinium chloride

Alessandra Capezzone et al.

Drugs in Context · 2025

Editorial support

New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience

Gabriella Iannuzzo et al.

Frontiers in Endocrinology · 2025

Editorial support

Resistance to conventional drug therapy and good response to lomitapide allowed the identification of a novel bi-allelic semi-dominant monogenic HoFH: a case report

Paolo Fornengo et al.

Current Medical Research and Opinion · 2025

Editorial support

Clinical features of acquired lipodystrophy after total body irradiation: a case report and mini review

Giuseppe Ancona

Current Medical Research and Opinion · 2025

Editorial support

Management of genetically determined kidney stone disease: consensus from a panel of urologists and nephrologists

Roberto Miano et al.

Minerva: Urology and Nephrology · 2025

Consensus methodology support

Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort

Alessandro Giunta et al.

Dermatology Practical & Conceptual · 2025

Editorial support

Prevention of Epiretinal Membrane Traction Progression with Topical Indomethacin Treatment: A Case Report and Literature Review

Amedeo Lucente et al.

Drugs in Context · 2025

Editorial support

Conservative management of paediatric dacryocystitis: a collection of clinical experiences highlighting effectiveness and parental satisfaction

Stefano Russo et al.

Drugs in Context · 2025

Editorial support

Optimizing urine albumin-to-creatinine ratio testing and referral pathways for chronic kidney disease: a nominal group technique consensus study among Italian experts

Irene Capelli et al.

Journal of Nephrology · 2025

Consensus methodology support

X-linked hypophosphatemia and tumor-induced osteomalacia: a narrative review and expert opinion on the diagnostic and therapeutic challenges in the era of burosumab

Maria Luisa Brandi et al.

Orphanet Journal of Rare Diseases · 2025

Editorial support

The correct nutritional intake in the prevention and treatment of skin lesions in patients with spinal cord injury

Alessandra Areni et al.

Journal of Clinical Medicine Research · 2026

Editorial support

Daridorexant and Insomnia in Clinical Practice: A Nominal Group Technique Consensus Study among Italian Sleep and Insomnia Experts

Luigi Ferini-Strambi et al.

2025

Consensus methodology support

Are we doing enough to treat cancer pain? The urgent need for action in oncology practice

Massimo Aglietta et al.

Future Oncology · 2025

Editorial support

MAPK pathway deregulation and immunotherapy efficacy in squamous cell lung carcinoma: results from the randomized, prospective SQUINT trial

Federico Cappuzzo et al.

Clinical Cancer Research · 2025

Editorial support

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial

Paolo Bossi et al.

European Journal of Cancer · 2025

Editorial support

Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: consensus statements from an Italian expert panel

Paolo Bossi et al.

Critical Reviews in Oncology/Hematology · 2025

Consensus methodology support